HOT OFF THE PRESS!!!!
I truly believe this company has something to offer... it just needs more time and attention...
Biosonics Seeks FDA Approval for Alternative to Viagra
June 30, 1998 11:35 AM
FORT WASHINGTON, Penn.--(BW HealthWire)--June 30, 1998-- Biosonics, Inc. BISN announced today that it is going forward with testing necessary in its efforts to obtain FDA marketing approval for MEGS(TM), a patented device which counteracts male impotence.
BISN holds a design patent for MEGS(TM) (Male Electronic Genital Stimulator) -- a non-invasive alternative to Pfizer's PFE Viagra and Vivus(TM) VVUS Muse(TM). Based on the market demand for Pfizer's Viagra(TM), BISN has decided to proceed with its efforts to make MEGS commercially available.
Jack Paller, Chief Executive Officer of BISN, explained the Company's decision, "MEGS(TM) is a non-invasive, non-pharmaceutical means of addressing male impotence. Given the public demand for a solution to male impotence, going forward with our efforts to make MEGS(TM) publicly available at this time makes sense."
BISN is involved in the development and marketing of electrotherapeutic and diagnostic devices to manage and treat several intractable medical conditions. To date, the Company holds six patents on its devices and has received FDA approval or clearance to market four of its products: Salitron(R) for dry mouth MOGN product Saligen), Cystotron(TM) for urinary incontinence EMPI and Utah Medical), Anotron(TM) for fecal incontinence and the BIDDS(TM) glove which is a diagnostic tool. For additional information on BISN, please contact Raymond Bary of the NIBAR Group at 415/474-1647. |
